Meredith Wadman
Surveillance is becoming a watchword for men with less-aggressive prostate cancer. If and when the disease progresses, new and newly-timed therapies are at hand.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: